Organigram Global Inc. (OGI) Stock

Organigram Global Inc. (OGI) is a Healthcare stock trading at $0.97 (as of 2026-06-18), with a market capitalization of $156.26M and a trailing P/E of -2.3. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Organigram Global Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products and adult-use recreational cannabis under multiple brands, and also sells cannabis edibles and concentrates, with sales via online and telephone channels, as well as wholesale supply of cannabis products to retailers and wholesalers.

Valuation — source: SEC EDGAR (first-party)
Price$0.97
Market Cap$156.26M
P/E Ratio-2.3
EV / EBITDA-1.6
Price / Book0.51
Price / Sales0.98
DCF Value (model)$1.59
DCF Upside vs Price64.5%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$159.84M
Net Margin-28.4%
Return on Equity-14.9%
Debt / Equity0.00
Current Ratio4.92
Revenue Growth (YoY)-1.1%
EPS Growth (YoY)-84.4%
Valuation vs Sector & Industry
Stock P/E-2.3
Sector P/E (Healthcare)20.9
Industry P/E (Pharmaceutical Products)17.0
vs Sector-111.1%
vs Industry-113.7%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderTidal Investments LLC ($3.42M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOJames H. Yamanaka
Employees1,093
CountryCA
IPO Date2019-05-21

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Editas Medicine, Inc. (EDIT)
  • Nuvectis Pharma, Inc. (NVCT)
  • Kalaris Therapeutics Inc (KLRS)
  • Cardiff Oncology, Inc. (CRDF)
  • Sagimet Biosciences Inc. (SGMT)
  • Climb Bio, Inc. (CLYM)
  • Journey Medical Corporation (DERM)
  • Cartesian Therapeutics, Inc. (RNAC)
OGI earnings history · OGI institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.